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article 
I Simms, P Rogers, M Catchpole, C A McGarrigle, A Nicoll, on behalf of the collaborative group* 
Objective: To describe trends in seroprevalence of undiagnosed HI\M infection among attenders 
at 15 genitourinary medicine clinics in England, Wales, and Northern Ireland between 1990 and 
1996. 
Method: Prospective, cross sectional sentinel serosurvey. Unlinked anonymous testing of remnant 
serum drawn for routine syphilis screening. 
Results: In 1996, the seroprevalence of undiagnosed HIV-1 infection was 5% in homosexual men, 
0.48% in heterosexual men, and 0.33% in heterosexual women. Between 1990 and 1996, there 
was a significant linear decrease in die seroprevalence of undiagnosed HIV-1 infection among 
homosexual and bisexual men within and outside London (p<0.0001; p=0.0141), equivalent to 
yearly decreases of 7.65% and 10.73% respectively. However, seroprevalence among homosexual 
and bisexual men under 25 years of age did not decline either inside or outside London. 
Seroprevalence among heterosexual men declined outside London (p<0.005), equivalent to an 
average annual decrease of 14.54%. There was a significant increase among male heterosexuals 
inside London (p<0.05) equivalent to a 8.09% increase per annum. Seroprevalence over time was 
unchanging among female heterosexuals both inside and outside London. Seroprevalence was 
significantly higher among those who injected drugs than those who did not report injecting in the 
following groups; homosexual and bisexual males within London (p<0.005), male heterosexuals 
both within and outside London (p<0.05;p<0.05) and female heterosexuals within London 
(p<0.05). 
Conclusions: The study highlights a significant burden of undiagnosed HIV-I infection more than 
15 years since the HIV epidemic began. Methods of offering HIV testing need to be reassessed to 
extend the practice of routinely testing for HIV in GUM clinics. HIV transmission among young 
homosexual and bisexual men continues. The contrasting trends between homosexual and bisexual 
men, injecting drug users, and heterosexuals attending GUM clinics indicate these groups should 
be considered separately. The substantial HIV seroprevalence in each group indicates that they 
should be priorities for targeted HIV prevention. 
(Sex Transm Inf 1999;75:332-336) 
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Introduction 
In England, Wales, and Northern Ireland, 
83% (23 660 of the 28 361) of HIV cases 
reported up to die end of 1997 were attributed 
to sexual transmission.1 Consequently, UK 
health campaigns have focused on safer sex 
as die key to HIV prevention.2 The 
seroprevalence of HIV-I infection among 
heterosexual women attending genitourinary 
medicine (GUM) services is four rimes that 
seen among pregnant women.3 This, together 
with the increasing burden of sexually 
transmitted infections (STIs) seen in GUM 
clinics, indicate that many attenders remain 
behaviourally vulnerable to HIV infection.4-6 
Attendcrs at GUM clinics are thus a prime 
sentinel group for monitoring HIV. 
 The survey of HIV seroprevalence 
among GUM clinic attenders, set up in 1990 
as part of the unlinked anonymous prevalence 
monitoring programme.7 uses an unlinked 
anonymous methodology to minimise 
participation bias and records previously 
diagnosed infections. The seroprevalence of 
undiagnosed HIV-1 infection can thus be 
estimated. This analysis was confined to 
undiagnosed HIV-1 infection 
 
 
for a number of reasons. Quality control 
studies and preliminary analyses indicated 
that diagnosed HIV-1 infection was 
increasingly managed in specialist HIV care 
outside routine GUM services during die 
course of the study. Consequently there was 
a marked decrease in the seroprevalence of 
diagnosed HIV-1 infection. This bias 
prevents comparison of the seroprevalence 
of diagnosed and undiagnosed HIV-1 
infection and thus the study was confined to 
undiagnosed HIV-1 infection which was 
unaffected by this source of bias. 
 Previous analyses of this dataset 
have shown that undiagnosed HIV-1 
infection accounts for a substantial 
proportion of HIV-I infections seen in GUM 
clinics and that patients with undiagnosed 
HIV-1 infection are more likely to have a 
newly acquired STI that those with 
diagnosed HIV-1 infection.6 HIV infection 
in people unaware of their HIV positive 
serostatus is thus an important public health 
problem, as they are unable to benefit from 
recent advances in HIV care, and may be 
the source of ongoing transmission.8 The 
analysis of undiagnosed infection among 
GUM clinic attenders repre- 
Table 1 Seroprevalence of HIV-1 infection among homosexual and bisexual men 
London Outside London  
% HIV-1 
infected (total) 
Adjusted OR* 
(91% CI) p Value 
% HIV-1 
infected (total) 
Adjusted OR* 
(95% CI) p Value 
Age group   <0.0001   0.1239 
<20 4.95 (364) 0.82 (0.50-1.36)  0.92 (435) 0 44 (0 16-1.25)  
20 to 24 5.83 (3226) 1.00  2.16 (1624) 1.00  
25 to 34 9.06 (10 504) 1.71 (1.45-2.01)  2.70 (3038) 1.27 (0.85-1.90)  
35 TO 44 9.06 (4061) 1.77 (1.47-2.12)  2.78 (1373) 1.30 (0.81-2.07)  
45+ 6.99 (1802) 1.35 (1.07-1.71)  2.19 (866) 1.02 (0.58-1.80)  
IDU 
Yes 13.05 (452) 1.65 (1.24-2.19) 0.0019 1.79 (112) 0.68 (0.17-2.77) 0.6713 
No 8.12 (18314) 1. 00  2.42 (7060) 1.00  
NA/NR† 8.82 (1191) 1.17 (0.94-1.45)  3.05 (164) 1.39 (0.56-3.47)  
Year 
1990-1 9 90 (475) 1.00 0.0004 4.30 (93) 1.00 0.1462 
1990-2 12.24 (915) 1.05 (0.73-1.52)  2.88 (278) 0.62 (0.18-2.13)  
1991-1 10.07 (1420) 0.85 (0.60-1.21)  2.88 (312) 056 (0.16-1.89)  
1991-2 9.69 (1104) 0.37 (0.61-1.26)  4.38 (274) 0.83 (0.26-2.71)  
1992-1 10.49 (915) 093 (0.64-1.35)  1.25 (401) 0.20 (0.05-0.80)  
1992-2 9.70 (1381) 0.33 (0.58-1.18)  2.94 (544) 0.49 (0.15-1.57)  
1993-1 9.84 (1138) 0.84 (0.58-1.21)  2.30 (740) 0.41 (0.13-1.30)  
1993-2 8.31 (1071) 0.71 (0.49-1.03)  3.57 (729) 0.62 (0.20-1.93)  
1994-1 8.33 (1212) 0.74 (0.51-1.07)  1.93 (624) 0.35 (0.10-1.16)  
1994-2 8.31 (1806) 0.79 (0.56-1.12)  2.20 (682) 0.39 (0.12-1.27)  
1995-1 6.83 (2256) 0.66 (0.47-0.93)  2 58 (638) 0.45 (0.14-1.43)  
1995-2 6. 80 (2237) 0.67 (0.47-0.94)  1.44 (019) 0.33 (0.10-1.10)  
1996-1 6.52 (2332) 0.63 (0.44-0.89)  1.85 (703) 0.30 (0.09-1.01)  
1996-2 6.08 (1695) 0.58 (0.40-0.83)  1.77 (679) 0.31 (0.09-1.01)  
* Adjusted for age, IDU, time (as a factor), and centre. 
† Not asked or not recorded. 
 
sents a measure of the underlying prevalence of HIV infection. 
The prevalence of HIV infection in people under 25 years of 
age approximates to recent transmission of infection.9 The aim 
of this analysis was thus to investigate differences and trends 
in undiagnosed HIV-1 infection by exposure category using 
data collected between 1990 and 1996. 
Patients and methods 
Between 1990 and 1994, 15 clinics were recruited, seven in 
London and eight outside London10; the data management and 
laboratory methods have been described previously.3 7 10 For 
each attender, the first specimen tested for syphilis serology 
within each calendar quarter was eligible for inclusion. Data 
items collected included the following: sexual orientation, age 
group (<20, 20-24, 25-34, 35-44, and 45 and over), known to 
be infected with HIV before the clinic visit, injecting drug use 
(IDU), HIV-1 test result from residual specimen, clinic, and 
quarter and year of attendance. Cases with diagnosed HIV-1 
infection (that is, those known to be HIV infected before 
attendance) were removed from the analysis. The data were 
stratified by exposure category (homosexual and bisexual 
male, heterosexual male, and heterosexual female). Data were 
analysed and presented according to whether clinics were 
inside or outside London.10 The data were aggregated to 6 
month periods. A separate analysis was undertaken for those 
under 25 years of age. 
 The three exposure categories were analysed 
separately using a logistic regression model in GLIM4.11 All 
two way interactions between the independent variables were 
investigated and the smallest adequate model fitted. The 
baselines for odds ratio calculation were: age 20-24, not 
known to be an IDU, and the first half of 1990. Trends in 
prevalence over time were investigated by fit ring suitable 
polynomi- 
als to a model that included time as a variable. Where 
overdispersion was found, rescaling was used in the 
subsequent analyses. 
Results 
A total of 315 477 attenders were included in the analysis, 
2805 of these were found to have undiagnosed HIV-1 
infection. Only 1795 (0.6%) of attenders objected to the study. 
These were evenly distributed among the exposure categories, 
were unlikely to have biased the results, and were excluded 
from the analysis.12 Seroprevalence of undiagnosed HIV-1 
infection by exposure category with adjusted odds ratios (OR) 
(adjusted by age, IDU, time, and centre) together with 95% 
confidence intervals (CIs) are shown in tables 1, 2, and 3. In 
1996, the seroprevalence of undiagnosed HIV-1 infection was 
5% in homosexual men. 0.48% in heterosexual men, and 
0.33% in heterosexual women. 
ASSOCIATION WITH AGE GROUP 
After adjustment for other factors, significant differences in 
HIV-1 seroprevalence by age group were seen in all exposure 
categories. For homosexual and bisexual males within 
London, seroprevalence of undiagnosed infection was 
significantly higher than the baseline (the 20-24 year age 
group) in those aged 25 and over (p<0.0001). Outside London 
no difference was seen between age groups. For heterosexual 
men, there were significant differences in HIV-1 
seroprevalence by age group both within and outside London 
(p<0.0001; p<0.001), highest seroprevalence being seen in 
those aged 25 or more. For heterosexual women, the 
seroprevalence inside London was significantly lower in the 
under 20 age group (p<0.0001), whereas outside London it 
was significantly higher in the 25-34 year age group 
(p<0.0001).
Table 2 Seroprgvaience of HIV-1 infection among heterosexual men 
London Outside London  
% HIV-1 
infected (total) 
Adjusted OR* 
 (91% CI) p Value 
% HIV-1 
infected (total) 
Adjusted OR* 
(95% CI) p Value 
Age group 
<20 0.23 (2196) 0 52 (0.21-1.30) <0.0001 0.08 (6483)’ 1.26 (0.46-3.46) 0.0001 
20 to 24 0.46 (10005) 1.00  0.06 (24711) 1.00  
15 to 34 0.96 (24 882) 2.08 (1.51-2.85)  0.18 (37247) 2.97 (1.70-5.20)  
35 id 44 1.30 (8667) 2.08 (2.04-4.07)  0.18 (14316) 3 09 (1.63-5.83)  
45+ 0.80 (4265) 1.78 (1.14-2.77)  0.17 (6443) 306 (1 45-6.43)  
IDL- 
Yes 2.01 (944) 1.92 (1.20-3.06) 0.0451 0.52 (953) 3.86 (1.56-9.53) 0.0396 
No 0.85 (44400) 1.00  0.14 (87 582) 1.00  
NA-NR† 0.88 (4671) 1.05 (0.73-1.51)  0.06 (1665) 0.54 (0.08-3.62)  
Year 
1990-1 0.79 (632) 1.00 0.0123 0.25 (1612) 1.00 0.2540 
1990-2 0.72 (1249) 0.76 (0.25-2.29)  0.29 (3841) 0.98 (0.31-3.11)  
1991-1 0.81 (1599) 0.84 (0.30-2.38)  0.13 (3804) 0.61 (0.17-2.12)  
1991-2 1.23 (1377) 1.36 (050-3.72)  0. 1 6 (3723) 0.51 (0.14-1.83)  
1992-1 0.72 (11 12) 0.80 (0.26-2.45)  0.18 (5105) 0.62 (0.19-208)  
1992-2 0.46 (1971) 0.51 (0.17-1.52)  0.17 (7085) 0.52 (0.16-1.68)  
1993-1 0.70 (2413) 0.90 (0.33-2.48)  0.10 (8789) 0.29 (0 08-0.98)  
1993-2 1.15 (3305) 1.47 (0.57-3.78)  0.11 (7909) 0.30 (0.09-1.04)  
1994-1 1.16 (4121) 1.54 (0.60-3.92)  0.15 (7181) 0.33 (0.10-1.15)  
1994-2 0.95 (5781) 1.40 (0.55-3.57)  0. 1 5 (7833) 0.41 (0.12-1.35)  
1995-1 0.77 (6499) 1.16 (046-2.96)  0.03 (7463) 0.23 (0.06-0.84)  
1995-2 0.65 (6820) 0 99 (0.39-2.54)  0.13 (8618) 0.34 (0.10-1 14)  
1996-1 0.90 (6913) 1.35 (0.53-3-40)  0.10 (8981) 0.27 (0.08-0.92)  
1996-2 1.01 (6223) 1.56 (0. 62-3. 94)  0.13 (8252) 0.36 (0 11-1.18)  
* Adjusted for age, IDU, time (as a factor), and centre. 
† Not asked or not recorded. 
 
ASSOCIATION WITH INJECTING DRUG USE 
A comparison was made between those known to have injected drugs 
and those who did not report injecting (baseline). Seroprevalence was 
significantly higher than the baseline among those who injected in die 
following exposure categories: homosexual and bisexual males within 
London (p<0.005), male heterosexuals both within and outside 
London (p<0.05; p<0.05), and female heterosexuals within London 
(p<0.05). 
TRENDS IN SEROPREVALENCE OF UNDIAGNOSED 
INFECTION, 1990-6 
For homosexual and bisexual men, there was a significant linear 
decrease over time in undiag- 
nosed HIV-1 infection both inside and outside London (p0.001; 
p<0.05), equivalent to yearly decreases of 7.65% (95%CL 5.09% to 
10.14%) and 10.73% (95% GL 2.21% to 18.51%) respectively. There 
was also a significant linear decrease among male heterosexuals 
outside London (p<0.005), equivalent to an annual decrease of 14-
54% (95% CL4.85% to 23.25%). However, inside London, there was 
a significant linear increase in HIV-1 seropreva-lence among male 
heterosexuals (p<0.05), equivalent to an 8.09% (95% CL 1.63% to 
14.96%) increase per annum. No trend in HIV-1 seroprevalence was 
seen for female heterosexuals within or outside London. 
Table 3 Seroprevalence of HIV-1 infection among heterosexual women 
London Outside London Factor 
% HIV-1 
infected (total) 
Adjusted OR* 
(91% CI) p Value 
% HIV-1 
infected (total) 
Adjusted OR* 
(95% CI) p Value 
Age group 
<20 0.22 (6040) 0.44 (0.24-0.78)  0.01 (13329) 0.14 (0.02-1 01)  
20 to 24 0.46 (19 856) 1.00 <0.0001 0.05 (34 945) 1.00 <0.0001 
25 to 34 0.61 (32555) 1.31 (1 01-1.68)  0.14 (26880) 2.79 (1.48-5.24)  
35 to 44 0.46 (8784) 0 96 (0.66-1.40)  0.10 (9160) 1.92 (O.S2-4.49)  
45+ 0.21 (2803) 0.45 (0.20-1.02)  0.11 (3617) 2.21 (0.72-6.77)  
IDU 
Yes 1.39 (717) 1.77 (1.47-5.22)  0.2S (354) 3.43 (0.48-24.65)  
No 0.48 (63 438) 1.00 0.0243 0.08 (751 265) 1.00 0.5670 
NA/NR† 0.58 (5883) 1.08 (0.73-1.60)  0.08 (2451) 1 29 (0.30-5.49)  
Year 
1990-1 0.48 (421) 1.00 0.9274 031 (329) 1.00 0.0971 
1990-2 0.41 (2193) 0.72 (0.15-3.34)  0.05 (2099) 0.08 (0.00-1.44)  
1991-1 0.50 (2408) 0.86 (0.19-3.84)  0.16 (3113) 0.30 (0.03-2.75)  
1991-2 041 (2172) 0.81 (0.17-3.76)  0.20 (3021) 0.34 (0.04-3.03)  
1992-1 0.59 (2019) 1-13 (0.25-5.07)  0.02 (4320) 0.05 (0.00-0.86)  
1992-2 0 43 (3012) 0.73 (0.16-3.25)  0.13 (5940) 0.28 (0.03-2.51)  
1993-1 0.58 (3789) 0.90 (0.21-3.86)  0.11 (7459) 0.21 (0.02-1.86)  
1993-2 0.32 (4337) 0.56 (0.12-2.45)  0.07 (7131) 0.13 (0.01-1.24)  
1994-1 0.51 (5337) 0.79 (0.18-3.34)  0.05 (6446) 0.09 (0.01-0.93)  
1994-2 0.45 (7357) 0.73 (0.17-3.07)  0.03 (7033) 0.05 (0.00-0.63)  
1995-1 0.47 (3375) 081 (0.19-3.39)  0.13 (6925) 0.25 (0.03-2.24)  
1995-2 0 50 (9453) O.83 (0.20-3.47)  0.05 (7935) 0.09 (0.01-0.95)  
1996-1 0.59 (9558) 0.97 (0.23-4.05)  0.06 (8477) 0.11 (0.01-1 08)  
1996-2 0.53 (86 07) 0.87 (0.21-3 65)  0.10 (7703) 0.17 (0.02-1.58)  
*Adjusted (or age, IDU, time (as a factor), and centre. 
†Not asked or not recorded. 
Table 4 Seroprevalence of HIV-1 infection among homosexual and bisexual men aged 25 or less: 
London Outside London  
% HIV-1 
infected (total) 
Adjusted OR* 
(95% CI) 
p Value % HIV-1 
infected total) 
Adjusted OR* 
(95% CI) 
p Value 
Age group 
<20 4.95 (364) 0.80 (0.48-1 32) 0.3698 0.92 (435) 0.43 (0 15-1.23) O.O822 
20 to 24 5.83 (3226) 1 00  2.16 (1624) 1.00  
1DU 
Yes 12.26 (106) 2.13 (1.15-3.94) 0-0645 0.00 (40) 0.00‡ 0.2527 
No 5.44 (3293) 1.00  1.88 (1967) 1.00  
NA/NR† 7.33 (101) 1.29 (0.72-2.32)  3.85 (52) 2.10 (0.46-9.67)  
Year 
1°90-1 4.17 (96) 1.00 0.1117 8.33 (24) 1.00 0.5461 
1990-2 1092 (238) 2.15 (0.72-6.45)  3.37 (89) 0.49 (0.07-3 32)  
1991-1 6.48 (293) 1.30 (0.42-3.96)  2.13 (94) 0.29 (0.04-2.33)  
1991-2 8.21 (207) 1.79 (0.58-5.50)  5 32 (94) 0.66 (0.11-4.06)  
1992-1 10.00 (150) 2.22 (0.71-6.95)  0.77 (130) 009 (0.01-1.08)  
1992-2 7.90 (291) 1.59 (0.53-4.79)  1.27 (157) 0.17 (0.02-1.42)  
1993-1 5.16 (194) 1.04 (0.31-3.45)  0.47 (214) 0.07 (001-0.84)  
1993-2 4.36 (185) 0 97 (0.29-3.30)  2.07 (193) 0.29 (0.04-2.02)  
1994-1 5.50 (182) 1.15 (0.35-3.81)  1.56 (192) 0.24 (0.03-1 77)  
1994-2 4.06 (345) 0.89 (0.28-2.81)  1.65 (182) 0.24 (0.03-1.72)  
1995-1 4.33 (416) 0.97 (0.32-2.99)  1,68 (179) 0.24 (0.03-1.74)  
1 995-2 3.34 (359) 0.74 (0.23-2.39)  1.97 (152) 0.28 (0.04-2 09)  
1996-1 4.66 (386) 1.12 (0.36-3.45)  2.54 (197) 0.32 (0.05-2.08)  
1990-2 4.44 (248) 0.95 (029-3.11)  1.23 (162) 0.15 (002-1.27)  
* Adjusted for age, IDU, time (as, a factor), and centre. 
† Not asked of not recorded. 
‡ Adjusted OR estimate very low with confidence interval (-ºº, +ºº) as no IDU was HIV positive 
HOMOSEXUAL AND BISEXUAL MEN AGED UNDER 
25 YEARS 
There was no difference in prevalence between the under 20 
and the 20-24 year olds either inside London (4.95% and 
5.83% respectively) or outside London (0.93% and 2.16% 
respectively) and, over the 7 year period, there was no trend in 
seroprevalence either inside or outside London (table 4). 
Although seroprevalence of undiagnosed HIV-1 infection was 
twice as high in those who injected drugs, this difference was 
not significant (p=0.06). 
Discussion 
Undiagnosed HIV-1 infection is important both to public 
health and to the surveillance of HIV. Identifying undiagnosed 
infections enables individuals to benefit from advances in 
treatment and care, and reduces the risk of transmission to 
HIV negative partners. However, it has been suggested that 
detection of HIV infection in UK clinics may be lower than in 
some other European countries.13 This analysis provides 
evidence that many infections remain undiagnosed after 
individuals have attended a GUM clinic. This is disturbing and 
supports the view that voluntary confidential testing should be 
strengthened in GUM clinics to increase the chance of early 
diagnosis.14 
 Over the period studied there was no indication of 
infection spreading beyond known risk groups. The contrast 
between London and other areas in terms of detected 
prevalence also indicates that infection has not diffused 
beyond the London area since the early 1990s. The HIV 
epidemic is focused on homosexual and bisexual men, the 
highest seroprevalences of undiagnosed HIV-1 infection were 
seen in this exposure category. The substantial burden of 
undiagnosed HIV-1 infection indicates that homosexual and 
bisexual men continue to place themselves at risk of HIV-1 
infection despite public health campaigns, an observation 
which has been made in behavioural and 
 
seroprevalence studies both in the United Kingdom and 
elsewhere.15-17 The acquisition of STIs by homosexual and 
bisexual men who are aware of their HIV infection, indicates 
that knowledge of HIV infection status does not eliminate 
behaviour associated with continuing risk of HIV 
transmission.7 10 16-18 
 The seroprevalence of undiagnosed HIV-1 infection 
could have been influenced by variations in study selection 
procedure but no evidence was found in any of the survey’s 
audit studies. Similarly, die seroprevalence of both diagnosed 
and undiagnosed HIV-1 infection could have been influenced 
by variations in testing practice but this is unlikely to have 
occurred as no changes were made to national testing policy 
during the period included in this analysis. 
 The reduction in seroprevalence of undiagnosed HIV-
1 infection in homosexual and bisexual men needs to be 
carefully interpreted. Declines have been seen in other 
countries but, as most studies do not record diagnostic status, 
these observations could be accounted for by variations in 
diagnosis and care.16 17 19 Since this study is based on 
undiagnosed infection, variations in case management (that is, 
die opening of specialist services attached to clinics taking 
part in the study) cannot account for the fall. Nor can it be 
explained by increasing diagnoses as the proportion of 
recognised infections has not changed in recent years.10 This 
study shows continuing transmission and incidence, indicated 
by the consistent, substantial seroprevalence of undiagnosed 
HIV-1 infection among homosexual and bisexual men under 
25 years of age and data from voluntary confidential HIV-1 
testing and incidence studies.20 Younger men are thought to 
have unsafe sex because they are less experienced in personal 
and/or sexual negotiation.16 18 21 Clearly, HIV prevention 
needs to target this group. Variations in transmission in older 
age groups remains unclear but the use of tests to distinguish 
recently acquired infection may be able to provide more 
information in this area.14 
 Although seroprevalence of un diagnosed HIV-1 
among heterosexuals was lower than homosexual and bisexual 
males, the significant increase among heterosexual males 
inside London and the stable sera prevalence among females is 
of particular concern. Sex between men and women accounted 
for 16% of AIDS cases and 20% of diagnosed HIV-1 
infections to the end of 1997,1 but heterosexual transmission is 
considered uncommon in England and Wales. Sixty five per 
cent of AIDS case reports probably acquired through sexual 
intercourse between men and women have been associated 
with exposure in Africa, the majority were reported from 
London.1 Country of birth data would allow a more 
comprehensive analysis of the heterosexual data but is only 
available for two of the seven years of the study and 
consequently was not included in this analysis. However, 
analysis of the available country of birth data indicates there 
was no difference in the proportion of undiagnosed HIV-1 
infection by world region of birth for homosexual and bisexual 
men or heterosexual men or heterosexual women.22 
 This study highlights the continuing problem of 
undiagnosed HIV-1 infection among attenders at GUM 
clinics, a problem which has also been recognised in pregnant 
women.23 Methods of offering HIV testing need to be 
reassessed if awareness to the benefits of HIV testing is be 
improved. 
This survey would not have been possible without the support 
of clinical, clerical, and laboratory staff at clinics and 
hospitals, whose help is gratefully acknowledged. The 
development of this survey, and others in the HIV prevalence 
monitoring programme in England and Wales, benefited from 
discussions with colleagues at the Scottish Centre for Infection 
and Environmental Health and Dr AV Swan (PHLS Statistics 
Unit). 
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